Mineralised Tissue Group, Tissue Engineering and Reparative Dentistry, School of Dentistry, Cardiff University, Heath Park, Cardiff, UK.
Clin Oral Implants Res. 2011 Jun;22(6):578-86. doi: 10.1111/j.1600-0501.2010.01992.x. Epub 2010 Nov 3.
Central to the process of osseointegration is the recruitment of mesenchymal progenitor cells to the healing site, their proliferation and differentiation to bone synthesising osteoblasts. The process is under the control of pro-inflammatory cytokines and growth factors. The aim of this study was to monitor these key stages of osseointegration and the signalling milieu during bone healing around implants placed in healthy and diabetic bone.
Implants were placed into the sockets of incisors extracted from the mandibles of normal Wistar and diabetic Goto-Kakizaki rats. Mandibles 1-12 weeks post-insertion of the implant were examined by histochemistry and immunocytochemistry to localise the presence of Stro-1- positive mesenchymal progenitor cells, proliferating cellular nuclear antigen proliferative cells, osteopontin and osteocalcin, macrophages, pro-inflammatory cytokines interleukin (IL)-1β, IL-6, tumour necrosis factor (TNF)-α and tumour growth factor (TGF)-β1. Image analysis provided a semi-quantification of positively expressing cells.
Histological staining identified a delay in the formation of mineralised bone around implants placed in diabetic animals. Within the diabetic bone, the migration of Stro-1 mesenchymal cells in the healing tissue appeared to be unaffected. However, in the diabetic healing bone, the onset of cell proliferation and osteoblast differentiation were delayed and subsequently prolonged compared with normal bone. Similar patterns of change were observed in diabetic bone for the presence of IL-1β, TNF-α, macrophages and TGF-β1.
The observed alterations in the extracellular presence of pro-inflammatory cytokines, macrophages and growth factors within diabetic tissues that correlate to changes in the signalling milieu, may affect the proliferation and differentiation of mesenchymal progenitor cells in the osseointegration process.
骨整合过程的核心是间充质祖细胞募集到愈合部位,增殖并分化为合成骨的成骨细胞。这个过程受促炎细胞因子和生长因子的控制。本研究旨在监测种植体周围健康和糖尿病骨愈合过程中的这些关键骨整合阶段和信号转导环境。
将种植体植入正常 Wistar 和糖尿病 Goto-Kakizaki 大鼠下颌切牙拔除后的牙槽窝中。植入后 1-12 周,通过组织化学和免疫细胞化学检查下颌骨,以定位 Stro-1 阳性间充质祖细胞、增殖细胞核抗原增殖细胞、骨桥蛋白和骨钙素、巨噬细胞、促炎细胞因子白细胞介素 (IL)-1β、IL-6、肿瘤坏死因子 (TNF)-α 和转化生长因子 (TGF)-β1 的存在。图像分析提供了阳性表达细胞的半定量。
组织学染色表明,在糖尿病动物中,植入物周围矿化骨的形成出现延迟。在糖尿病骨中,愈合组织中 Stro-1 间充质细胞的迁移似乎不受影响。然而,在糖尿病愈合骨中,细胞增殖和成骨细胞分化的起始延迟,随后与正常骨相比延长。在糖尿病骨中,IL-1β、TNF-α、巨噬细胞和 TGF-β1 的存在也观察到类似的变化模式。
在与信号转导环境变化相关的糖尿病组织中观察到促炎细胞因子、巨噬细胞和生长因子的细胞外存在的改变,可能会影响间充质祖细胞在骨整合过程中的增殖和分化。